Task 7: Multi-evidence Natural Language Inference for Clinical Trial Data (NLI4CT)

Codalab competition

The Dataset is released! Please visit the Codalab competition website to participate in the task.

Motivation

In recent years, there has been a significant increase in the publications of Clinical Trial Reports (CTRs). Currently, there exists in excess of 10,000 CTRs for Breast Cancer alone. Over time it has become infeasible for clinical practitioners to stay updated on all current literature in order to provide personalized evidence-based care (DeYoung et al., 2020). In this context, Natural Language Inference (NLI) brings an opportunity to support the large-scale interpretation and retrieval of medical evidence. Successful development could significantly enhance the way we connect the latest evidence to support personalised care (Sutton et al.,2020).

Task Overview

Multi-evidence Natural Language Inference for Clinical Trial Data (NLI4CT)

This task is based on a collection of breast cancer CTRs (extracted from https://clinicaltrials.gov/ct2/home), statements, explanations, and labels annotated by domain expert annotators. It consists of 2 sub-tasks. Participants can select one or more tasks depending on their preference.

Task 1: Textual Entailment

For the purpose of the task, we have summarised the collected CTRs into 4 sections:

The annotated statements are sentences with an average length of 19.5 tokens, that make some type of claim about the information contained in one of the sections in the CTR premise. The statements may make claims about a single CTR or compare 2 CTRs. Task 1 is to determine the inference relation (entailment vs contradiction) between CTR - statement pairs.

Task 2:  Evidence retrieval

Given a CTR premise, and a statement, output a set of supporting facts, extracted from the premise, necessary to justify the label predicted in Task 1.

Organisers

Contacts

Please join our Google group for direct communication at nli4ct@googlegroups.com

For any questions, feel free to contact us at nli4clinicaltrials@gmail.com

Follow us on Twitter @NLI4CT

References